Tanzania: Study Warns Rising Drug-Resistant Infections Among Newborns

Tanzanian researchers have warned of a growing threat of severe, multi-drug resistant infections among newborns. A study conducted at Bugando Medical Centre found that neonatal sepsis remains a major concern due to infants' immature immune systems. The study, titled "Gut Bacterial Microbiome Diversity and Multi Drug Resistant Neonatal Sepsis Among Neonates Admitted at Bugando Medical Centre in Mwanza, Tanzania," highlights the need for improved diagnosis, infection prevention, and responsible antibiotic use.

Of the 327 newborns studied, 16.2% were found to have bloodstream infections caused mainly by Gram-negative bacteria, with Klebsiella pneumoniae and Acinetobacter species being the leading culprits. The study also revealed high resistance to common antibiotics like cephalosporins, aminoglycosides, and fluoroquinolones. While carbapenems remained effective against certain Klebsiella pneumoniae isolates, their effectiveness must be preserved through responsible prescribing.

Researchers developed a diagnostic algorithm combining birth weight, C-reactive protein concentrations, and neutrophil count, which achieved an area under the curve of 0.82 and specificity of 97%, but had a sensitivity of only 43%. Further validation is needed before widespread use. The study also found that Klebsiella or Escherichia-Shigella were dominant in the microbial community of infected newborns, suggesting possible transmission within the neonatal unit.

Dr Msanga urged parents to seek immediate medical attention if newborns display certain symptoms and cautioned against administering antibiotics without medical guidance.